140 related articles for article (PubMed ID: 21563195)
1. Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.
Shui IM; Stark JR; Penney KL; Schumacher FR; Epstein MM; Pitt MJ; Stampfer MJ; Tamimi RM; Lindstrom S; Sesso HD; Fall K; Ma J; Kraft P; Giovannucci E; Mucci LA
Prostate; 2012 Feb; 72(2):209-16. PubMed ID: 21563195
[TBL] [Abstract][Full Text] [Related]
2. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
[TBL] [Abstract][Full Text] [Related]
3. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
4. Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.
Wang MH; Helzlsouer KJ; Smith MW; Hoffman-Bolton JA; Clipp SL; Grinberg V; De Marzo AM; Isaacs WB; Drake CG; Shugart YY; Platz EA
Prostate; 2009 Jun; 69(8):874-85. PubMed ID: 19267370
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in RNASEL associated with prostate cancer risk and progression.
Meyer MS; Penney KL; Stark JR; Schumacher FR; Sesso HD; Loda M; Fiorentino M; Finn S; Flavin RJ; Kurth T; Price AL; Giovannucci EL; Fall K; Stampfer MJ; Ma J; Mucci LA
Carcinogenesis; 2010 Sep; 31(9):1597-603. PubMed ID: 20576793
[TBL] [Abstract][Full Text] [Related]
6. Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men.
Kim HJ; Bae JS; Chang IH; Kim KD; Lee J; Shin HD; Lee JY; Kim WJ; Kim W; Myung SC
World J Urol; 2012 Apr; 30(2):225-32. PubMed ID: 21553150
[TBL] [Abstract][Full Text] [Related]
7. Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk.
Shui IM; Mucci LA; Wilson KM; Kraft P; Penney KL; Stampfer MJ; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):118-26. PubMed ID: 23125333
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation across C-reactive protein and risk of prostate cancer.
Markt SC; Rider JR; Penney KL; Schumacher FR; Epstein MM; Fall K; Sesso HD; Stampfer MJ; Mucci LA
Prostate; 2014 Jul; 74(10):1034-42. PubMed ID: 24844401
[TBL] [Abstract][Full Text] [Related]
9. Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.
Lindström S; Hunter DJ; Grönberg H; Stattin P; Wiklund F; Xu J; Chanock SJ; Hayes R; Kraft P
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):873-6. PubMed ID: 20200442
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.
Shui IM; Mucci LA; Kraft P; Tamimi RM; Lindstrom S; Penney KL; Nimptsch K; Hollis BW; Dupre N; Platz EA; Stampfer MJ; Giovannucci E
J Natl Cancer Inst; 2012 May; 104(9):690-9. PubMed ID: 22499501
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 4 genetic variation and advanced prostate cancer risk.
Cheng I; Plummer SJ; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):352-5. PubMed ID: 17301271
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer.
Chen YC; Huang YL; Platz EA; Alderete JF; Zheng L; Rider JR; Kraft P; Giovannucci E; Sutcliffe S
Cancer Causes Control; 2013 Jan; 24(1):175-80. PubMed ID: 23179660
[TBL] [Abstract][Full Text] [Related]
13. The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men.
Song J; Kim DY; Kim CS; Kim HJ; Lee DH; Lee HM; Ko W; Lee G
Cancer Genet Cytogenet; 2009 Apr; 190(2):88-92. PubMed ID: 19380025
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.
Stevens VL; Hsing AW; Talbot JT; Zheng SL; Sun J; Chen J; Thun MJ; Xu J; Calle EE; Rodriguez C
Int J Cancer; 2008 Dec; 123(11):2644-50. PubMed ID: 18752252
[TBL] [Abstract][Full Text] [Related]
15. Common variation in BRCA1 may have a role in progression to lethal prostate cancer after radiation treatment.
Sanchez A; Schoenfeld JD; Nguyen PL; Fiorentino M; Chowdhury D; Stampfer MJ; Sesso HD; Giovannucci E; Mucci LA; Shui IM
Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):197-201. PubMed ID: 26926928
[TBL] [Abstract][Full Text] [Related]
16. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345
[TBL] [Abstract][Full Text] [Related]
17. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM; Lindström S; Kibel AS; Berndt SI; Campa D; Gerke T; Penney KL; Albanes D; Berg C; Bueno-de-Mesquita HB; Chanock S; Crawford ED; Diver WR; Gapstur SM; Gaziano JM; Giles GG; Henderson B; Hoover R; Johansson M; Le Marchand L; Ma J; Navarro C; Overvad K; Schumacher FR; Severi G; Siddiq A; Stampfer M; Stevens VL; Travis RC; Trichopoulos D; Vineis P; Mucci LA; Yeager M; Giovannucci E; Kraft P
Eur Urol; 2014 Jun; 65(6):1069-75. PubMed ID: 24411283
[TBL] [Abstract][Full Text] [Related]
19. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.
Cheng I; Stram DO; Penney KL; Pike M; Le Marchand L; Kolonel LN; Hirschhorn J; Altshuler D; Henderson BE; Freedman ML
J Natl Cancer Inst; 2006 Jan; 98(2):123-34. PubMed ID: 16418515
[TBL] [Abstract][Full Text] [Related]
20. The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium.
Davies NM; Gaunt TR; Lewis SJ; Holly J; Donovan JL; Hamdy FC; Kemp JP; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; ; Lathrop M; Smith GD; Martin RM
Cancer Causes Control; 2015 Nov; 26(11):1603-16. PubMed ID: 26387087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
